Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
2014-06-30
NCT00601900Uploaded 01-18-2020
Access via NCI by Request
PDS UID: nci-data-378
Endocrine Therapy With or Without Anti-VEGF Therapy: A Randomized, Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC 704865) for Women With Hormone Receptor-Positive Advanced Breast Cancer
Files: NCT00601900-D2
Data DictionaryNCT00601900-D2-Data-Dictionary_2.pdf
DATANCT00601900-D2-Dataset_2.csv
OTHERREADME.pdf
Files: NCT00601900-D1
Data DictionaryNCT00601900-D1-Data-Dictionary_3.pdf
DATANCT00601900-D1-Dataset_2.csv
OTHERREADME.pdf